丛集性头痛炎症生物标志物的独特改变:病例对照研究
基于丹麦丛集性头痛生物样本库的前瞻性病例对照研究,检测412名成人(99例慢性丛集性头痛、108例发作期阵发性丛集性头痛、105例缓解期阵发性丛集性头痛、100名年龄性别匹配对照)的45种细胞因子。与对照相比,发作期阵发性丛集性头痛有13种细胞因子改变(p<0.05),缓解期有3种(p<0.05),慢性丛集性头痛有10种(p<0.05);抑瘤素M在三种疾病状态均显著升高(p<0.05)。慢性与发作期阵发性丛集性头痛的细胞因子改变模式不同,校正潜在混杂因素后IL-1β与慢性而非发作期阵发性丛集性头痛显著相关(p<0.05)。
要点
- 与对照相比,发作期阵发性丛集性头痛13种细胞因子改变,缓解期3种,慢性丛集性头痛10种(均p<0.05)。
- 抑瘤素M在慢性、发作期阵发性及缓解期阵发性丛集性头痛三种状态均较对照显著升高(p<0.05)。
- 校正混杂因素后,IL-1β与慢性而非发作期阵发性丛集性头痛显著相关(p<0.05)。
核心结论
- 与对照相比,丛集性头痛三种状态均存在免疫系统改变;抑瘤素M升高,是未来研究的有前景靶点;阵发性与慢性丛集性头痛之间的独特改变引人注目,需进一步研究免疫系统以更好理解其在预测疾病活动度和治疗反应中的潜在作用。
研究设计与样本
- 前瞻性病例对照研究,从丹麦丛集性头痛生物样本库纳入成人参与者,测量45种细胞因子。
- 丛集性头痛按国际头痛疾病分类第三版诊断,对照按年龄和性别匹配。
- 共分析412人:慢性丛集性头痛99例、发作期阵发性丛集性头痛108例、缓解期阵发性丛集性头痛105例、成功匹配的对照100名。
主要发现
- 与对照相比,发作期阵发性丛集性头痛有13种细胞因子改变(p<0.05),缓解期有3种(p<0.05),慢性丛集性头痛有10种(p<0.05)。
- 抑瘤素M在三种疾病状态均较对照显著升高(p<0.05)。
- 慢性丛集性头痛与发作期阵发性丛集性头痛之间细胞因子改变模式不同;校正潜在混杂因素的logistic回归模型中,IL-1β与慢性而非发作期阵发性丛集性头痛显著相关(p<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Investigate the immune system's role in cluster headache by analyzing cytokines in people with cluster headache and headache-free controls, and explore if certain cytokines could predict a specific phenotype. METHODS: We measured 45 cytokines in adult participants from the Danish Cluster Headache Biobank in a prospective case-control setup. People with cluster headache were diagnosed according to the International Classification of Headache Disorders third-edition. Controls were matched for age and sex. RESULTS: A total of 412 were analyzed deriving from 99 with chronic cluster headache, 108 with episodic cluster headache (ECH) in bout, 105 with ECH in remission, and 100 successfully matched controls. Compared with controls, 13 cytokines were altered for ECH in bout (p < 0.05), 3 in remission (p < 0.05), and 10 for chronic cluster headache (p < 0.05). Oncostatin m was significantly elevated in all 3 disease states compared with controls (p < 0.05). Overall, the investigated cytokines showed distinct patterns of alterations between chronic cluster headache and episodic cluster headache in bout and, interestingly, IL-1β was significantly associated with having chronic cluster headache rather than episodic in bout in a logistic regression model adjusting for potential confounders (p < 0.05). INTERPRETATION: Findings show that the immune system is altered in all 3 states of cluster headache compared with controls. Oncostatin m was elevated, constituting a promising target for future studies. The distinct alterations between episodic and chronic cluster headache are striking and urges further research of the immune system in cluster headache to better understand its potential role in prediction of disease activity and treatment response. ANN NEUROL 2025;98:4-18.
引用
- Lund NLT, Westgate CSJ, Søborg MK, et al. Distinct Alterations of Inflammatory Biomarkers in Cluster Headache: A Case Control Study. Ann Neurol. 2025. PMID: 39981939. doi:10.1002/ana.27205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。